Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1179392 NEW YORK, NY
Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,037,903
+$524,228 QoQ
Shares Held
233,270
-17.5% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 311 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. AMRX ranks #22 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 2,076,260 $349,932,860
2 BCRX
Biocryst Pharmaceuticals Inc
 6,775,349 $67,753,490
3 SUPN
Supernus Pharmaceuticals, Inc.
 1,184,378 $55,085,420
4 ALKS
Alkermes plc.
 1,038,311 $54,407,496
5 KNSA
Kiniksa Pharmaceuticals International, plc
 561,480 $35,906,646
6 ZTS
Zoetis Inc.
 386,428 $27,768,716
7 LQDA
Liquidia Corp
 266,829 $21,274,276
8 IRWD
Ironwood Pharmaceuticals Inc
 4,556,089 $19,181,134

All Filings in AMRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,037,903 233,270
2026-03-31 $3,513,675 282,677
2025-12-31 $3,792,952 301,028
2025-09-30 $696,035 69,534
2025-06-30 $143,557 17,745
2025-03-31 $1,405,326 167,700
2024-09-30 $226,678 27,245
2024-06-30 $366,953 57,788
2024-03-31 $713,055 117,666
2023-12-31 $1,281,795 211,169
2023-09-30 $1,332,502 315,759
2023-06-30 $1,431,536 461,786
2023-03-31 $265,758 191,193
2022-12-31 $1,150,578 578,180
2022-03-31 $494,970 118,698
2021-12-31 $1,315,904 274,719
2021-09-30 $2,096,548 392,612
2021-06-30 $529,372 103,393
2021-03-31 $4,978,638 739,768